LSE - Delayed Quote GBp
Faron Pharmaceuticals Oy (FARN.L)
202.50
-7.50
(-3.57%)
At close: 4:14:01 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-22,971
-22,971
-23,806
-22,993
-22,218
Investing Cash Flow
-226
-226
-123
-385
-473
Financing Cash Flow
25,816
25,816
23,983
23,478
25,590
End Cash Position
9,503
9,503
6,876
6,990
6,853
Capital Expenditure
-226
-226
-123
-385
-474
Issuance of Capital Stock
31,850
31,850
26,031
13,445
25,559
Issuance of Debt
3,200
3,200
64
10,389
662
Repayment of Debt
-3,371
-3,371
-861
-105
-122
Free Cash Flow
-23,197
-23,197
-23,929
-23,378
-22,692
12/31/2021 - 11/17/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
25I.SG ImmuPharma PLC
0.0185
-7.50%
CINGW Cingulate Inc.
0.0400
+20.85%
NANOFH.HE Nanoform Finland Oyj
1.0380
-0.19%
BVXP.L Bioventix PLC
2,500.00
0.00%
AVCT.L Avacta Group Plc
31.00
-6.06%
NBTX Nanobiotix S.A.
3.2600
-1.21%
BIOR Biora Therapeutics, Inc.
0.2200
0.00%
OXB.L Oxford Biomedica plc
299.50
+0.67%
IVA Inventiva S.A.
3.7000
-3.39%
SYRE Spyre Therapeutics, Inc.
14.65
+3.02%